Clinical Study
Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size
Figure 4
Distribution of myopic progression in the atropine and control groups at 6-month follow-up. In the atropine group, 59.4%, 34.3%, and 6.3% participants progressed by <0.5 D, 0.5–0.99 D, and ≥1.0 D, respectively. In comparison, 31.9%, 46.8%, and 21.3% participants in the control group progressed by <0.5 D, 0.5–0.99 D, and ≥1.0 D, respectively. D = diopter.